Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How would you design PORT volumes for a patient with NSCLC and positive chest wall margin?

2
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

A positive surgical margin (bronchial, vascular, parenchymal) after a typical lobectomy/pneumonectomy for NSCLC is rare (~1-2%- JTO 2015;10:1625), a bit higher after sublobar resection, and even higher after chest wall resection (14% in our series- Tandberg et al. Clin Lung Cancer 2016). The most ac...

Do you offer TTF for patients with newly diagnosed GBM?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Oakland University William Beaumont School of Medicine

I would describe it as unethical to not discuss TTF as an adjuvant therapy in the majority of patients with a GBM. The size effect in the randomized trial was twice that of temozolamide and we all agree on strongly recommending in general. The benefit was an overall survival benefit and the practi...

For postoperative gastric patients status post total gastrectomy, how do you approach anastamotic coverage?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Brigham and Women's Hospital

In the Gunderson re-op studies, local regional recurrences occurred in 38% of patients when assessed clinically, 67% when assessed by re-operation and 80-90% at autopsy. Of the local recurrences, 25% occurred at the anastomosis or duodenal stump when assessed clinically or by reoperation, and 50-60%...

Who discusses and prescribes TTFs at your facility?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Florida International University - Herbert Wertheim College of Medicine

Strong multi-disciplinary support is key to developing a robust TTF program. Our neuro-oncologist and surgeons are fortunately on board with discussing this as a standard option for GBM patients. TTF is prescribed by the radiation oncologists at our institution.

Is it appropriate to use moderate hypofractionation for the treatment of patients with high-risk prostate cancer?

10
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Fox Chase Cancer Center

At Fox Chase, we conducted a phase III randomized prospective clinical trial comparing conventionally fractionated IMRT with moderately hypofractionated IMRT from 2002-2008, for men with intermediate and high risk prostate cancer. Men were randomized to 76 Gy in 38 fractions or 70.2 Gy in 26 fractio...

How do you decide on the modality of consolidative treatment after a CR in primary CNS lymphoma patients treated with a high-dose methotrexate regimen?

1
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Washington University School of Medicine

Unless there are contraindications to autologous transplant I favor consolidation with autologous transplant. The long term complications of whole brain XRT include significant neurocognitive deficits. These approaches are rough equal with regards to efficacy.

At your institution how are cervical cancer patients managed who are intraoperatively found by frozen section to have positive pelvic lymph nodes?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

At our institution if found intraoperatively then we abondon radical hysterectomy and treat with definitive chemo RT. Idea is to avoid increased complications with combination of surgery,RT and chemo vs. only chemo RT

Do you have a tolerance dose for a skin graft when treating a high-risk skin cancer?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Oklahoma College of Medicine

Surprisingly, skin grafts are extremely tolerant of radiation therapy. This is probably due to the low oxygenation saturation. I generally treat across the skin graft, considering it nothing more than normal tissue when I am attempting to either prophylactically or specifically treat cancer in and a...

For clinically node negative large squamous cell carcinomas of the scalp vertex, would you electively treat the nodes?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan Kettering Cancer Center

In most situations, no. I might consider it for a patient coming in for adjuvant radiotherapy to the primary site, if I do not anticipate that the patient would be able to undergo a salvage therapeutic lymphadenectomy over the next 3-4 years because of medical comorbidity. The rationale is that ele...

How do you manage patients who need radiation for synchronous locally advanced head and neck cancer and locally advanced breast cancer?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Have never done it but dont see any reason why RT if needed can't be addressed to both sites at the same time